Curi RMB Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Curi RMB Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.4M	Buy	143,846 +96,157	+202%	+$12M	0.33%	81
2025 Q4	$5.81M	Buy	+47,689	New	+$5.47M	0.1%	202
2019 Q3	–	Sell	-2,700	Closed	-$237K	–	802
2019 Q2	$237K	Hold	2,700	–	–	0.01%	669
2019 Q1	$244K	Buy	+2,700	New	+$230K	0.01%	706
2018 Q4	–	Sell	-3,557	Closed	-$341K	–	1000
2018 Q3	$341K	Buy	3,557 +697	+24%	+$67.6K	0.01%	704
2018 Q2	$272K	Sell	2,860 -13,597	-83%	-$1.25M	0.01%	751
2018 Q1	$1.44M	Sell	16,457 -100	-0.6%	-$9.13K	0.04%	441
2017 Q4	$1.41M	Hold	16,557	–	–	0.04%	430
2017 Q3	$1.43M	Hold	16,557	–	–	0.04%	393
2017 Q2	$1.28M	Buy	16,557 +157	+1%	+$11.1K	0.04%	420
2017 Q1	$1.14M	Buy	16,400 +3,400	+26%	+$228K	0.05%	290
2016 Q4	$769K	Buy	+13,000	New	+$802K	0.04%	273

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Curi RMB Capital's XBI Position: Q1 2026 in Review

Curi RMB Capital increased its State Street SPDR S&P Biotech ETF (XBI) stake by 202% in Q1 2026, buying an estimated $12M and bringing the position to 143,846 shares worth $18.4M. The position accounts for 0.33% of the portfolio, ranked #81.

Curi RMB Capital first reported a position in XBI in Q4 2016 and has held it in 12 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Curi RMB Capital held 143,846 shares of State Street SPDR S&P Biotech ETF worth $18.4M as of Q1 2026.
Curi RMB Capital bought 96,157 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $12M.
State Street SPDR S&P Biotech ETF made up 0.33% of Curi RMB Capital's portfolio in Q1 2026, its #81 holding.
Curi RMB Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 12 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.